AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31256116 — intervention group
Group type: COMPARATOR
Intervention: Health education pamphlets (control group)
Number of subjects: 50
Study 29122965 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g of dairy protein supplementation
Number of subjects: 30
Study 29122965 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 27112273 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized risk assessment leaflet
Number of subjects: 960
Study 27112273 — intervention group
Group type: COMPARATOR
Intervention: Standardized leaflet with general information
Number of subjects: 960
Study 24240607 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin, administered in cycles of 7-10 days per month over a period of 3 months
Number of subjects: 1003
Study 24240607 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 1003
Study 22321770 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin (200 mg every 12 h for 10 days)
Number of subjects: 509
Study 22321770 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (125 mg every 6 h for 10 days)
Number of subjects: 509
Study 20072053 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) strength training for 4 weeks, 20 minutes per session, 4 sessions per week
Number of subjects: 20
Study 20072053 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ES training)
Number of subjects: 20
Study 17912636 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole monotherapy
Number of subjects: 8010
Study 17912636 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen monotherapy
Number of subjects: 8010
Study 16053194 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 days of ceftriaxone
Number of subjects: 201
Study 16053194 — intervention group
Group type: COMPARATOR
Intervention: 28 days of ceftriaxone
Number of subjects: 201
Study 12572098 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular overdenture on two implants (IMP-group)
Number of subjects: 149
Study 12572098 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete denture (VP-group)
Number of subjects: 149
Study 12572098 — intervention group
Group type: COMPARATOR
Intervention: Complete denture after preprosthetic surgery (MVP-group)
Number of subjects: 149
Study 10347961 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone
Number of subjects: 30
Study 10347961 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 30
Study 10347961 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalatory corticosteroids therapy with educational program (EDUCASMA)
Number of subjects: 30
Study 10347961 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 8562152 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with LV (200 mg/m2) plus 5‐FU (350 mg/m2), both given i.v. (days 1‐4) and i.p. (days 1 and 3) every 4 weeks for a total of six courses
Number of subjects: 121
Study 8562152 — intervention group
Group type: COMPARATOR
Intervention: Observation (standard care)
Number of subjects: 121
Study 2527993 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 160
Study 2527993 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 160
Study 2527993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 824924 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of fat emulsion
Number of subjects: 0
Study 824924 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fat emulsion)
Number of subjects: 0
Study 824924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomized patients after fat infusion
Number of subjects: 0
Study 31964118 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (6 mL of 2% lidocaine)
Number of subjects: 75
Study 31964118 — intervention group
Group type: COMPARATOR
Intervention: Saline (6 mL of saline)
Number of subjects: 75
Study 31964118 — intervention group
Group type: COMPARATOR
Intervention: Non-rehydrated packs
Number of subjects: 75
Study 30339737 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve hydrodissection with 5-ml normal saline injection
Number of subjects: 34
Study 30339737 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal saline injection)
Number of subjects: 34
Study 30339737 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve hydrodissection
Number of subjects: 34
Study 28115299 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive web-based intervention
Number of subjects: 1041
Study 28115299 — intervention group
Group type: COMPARATOR
Intervention: Plain-text web-based intervention
Number of subjects: 1041
Study 28115299 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (interactive and plain-text)
Number of subjects: 1041
Study 25666468 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 1609
Study 25666468 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent goal‐based monitoring with pharmacotherapy
Number of subjects: 1609
Study 25666468 — intervention group
Group type: COMPARATOR
Intervention: Education and support
Number of subjects: 1609
Study 23337416 — intervention group
Group type: EXPERIMENTAL
Intervention: TOF <0.9 group
Number of subjects: 149
Study 23337416 — intervention group
Group type: COMPARATOR
Intervention: Control group (TOF ≥0.9)
Number of subjects: 149
Study 21358389 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC) for 2 hours per week
Number of subjects: 112
Study 21358389 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 112
Study 21358389 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 112
Study 21358389 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram and Health Education (HE)
Number of subjects: 112
Study 21358389 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 112
Study 19538921 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention sessions founded in motivational interviewing techniques (2 sessions)
Number of subjects: 363
Study 17516709 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 0
Study 17516709 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 0
Study 15479202 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention model (use of hand alcohol and gloves)
Number of subjects: 0
Study 15479202 — intervention group
Group type: COMPARATOR
Intervention: Regular model (use of soap and water)
Number of subjects: 0
Study 15479202 — intervention group
Group type: COMPARATOR
Intervention: Regular model (use of gloves)
Number of subjects: 0
Study 15479202 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention model (use of gloves)
Number of subjects: 0
Study 11500348 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (n = 28)
Number of subjects: 41
Study 11500348 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 41
Study 9332625 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 179
Study 9332625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study 8398021 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional TENS
Number of subjects: 31
Study 8398021 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture‐like TENS
Number of subjects: 31
Study 8398021 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 31
Study 8398021 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm skin temperature
Number of subjects: 31
Study 8398021 — intervention group
Group type: EXPERIMENTAL
Intervention: Ring finger skin temperature
Number of subjects: 31
Study 3536526 — intervention group
Group type: EXPERIMENTAL
Intervention: Halsted radical mastectomy (n 349)
Number of subjects: 701
Study 3536526 — intervention group
Group type: COMPARATOR
Intervention: Quadrantectomy with axillary dissection and radiotherapy (n 352)
Number of subjects: 701
Study 30376904 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensationalized media exposure
Number of subjects: 102
Study 30376904 — intervention group
Group type: COMPARATOR
Intervention: Non-sensationalized media exposure
Number of subjects: 102
Study 29768525 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk supplemented with Lactobacillus rhamnosus 5x10^6 and Bifidobacterium longum 3x10^6 (intervention group)
Number of subjects: 363
Study 29768525 — intervention group
Group type: COMPARATOR
Intervention: Standard milk (control group)
Number of subjects: 363
Study 27285856 — intervention group
Group type: EXPERIMENTAL
Intervention: MSB11022
Number of subjects: 237
Study 27285856 — intervention group
Group type: COMPARATOR
Intervention: US-RP
Number of subjects: 237
Study 27285856 — intervention group
Group type: COMPARATOR
Intervention: EU-RMP
Number of subjects: 237
Study 24165376 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseled group (25 couples)
Number of subjects: 74
Study 24165376 — intervention group
Group type: COMPARATOR
Intervention: Control group (24 couples)
Number of subjects: 74
Study 22137256 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA-rich oil
Number of subjects: 30
Study 22137256 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich oil
Number of subjects: 30
Study 22137256 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA-rich oil (males)
Number of subjects: 30
Study 22137256 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich oil (females)
Number of subjects: 30
Study 22137256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 21055511 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetoscopic selective laser coagulation (FSLC)
Number of subjects: 128
Study 21055511 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 128
Study 17988947 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 514
Study 17988947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 514
Study 16333385 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional three dose scheme (month 0, 1, 6)
Number of subjects: 89
Study 16333385 — intervention group
Group type: EXPERIMENTAL
Intervention: Two dose brief scheme (month 0, 1)
Number of subjects: 89
Study 16333385 — intervention group
Group type: EXPERIMENTAL
Intervention: Three dose brief scheme (month 0, 1, 2)
Number of subjects: 89
Study 12882862 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprandial insulin aspart (immediately before meal start)
Number of subjects: 76
Study 12882862 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial insulin aspart (immediately after a meal or a maximum of 30 min after meal start)
Number of subjects: 76
Study 11213533 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g/day)
Number of subjects: 36
Study 11213533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 8636580 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants in the randomized trial
Number of subjects: 7191
Study 8636580 — intervention group
Group type: COMPARATOR
Intervention: Nonparticipants
Number of subjects: 7191
Study 1377307 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release verapamil (240 mg once daily)
Number of subjects: 20
Study 1377307 — intervention group
Group type: COMPARATOR
Intervention: Nitrendipine (20 mg once daily)
Number of subjects: 20
Study 6383268 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 105
Study 6383268 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylactic antibiotics)
Number of subjects: 105
Study 3742933 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 12
Study 3742933 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (300 mg)
Number of subjects: 12
Study 3742933 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 12
Study 3742933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30199451 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal load training
Number of subjects: 45
Study 30199451 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal strength training (squats and deadlifts)
Number of subjects: 45
Study 30199451 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosive strength training (power clean and high pull)
Number of subjects: 45
Study 30199451 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical jumping exercises
Number of subjects: 45
Study 29564847 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training at maximal fat oxidation intensity (FATmax) for 1 hour/day, 3 days/week for 12 weeks
Number of subjects: 31
Study 28887315 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitrate (600 mg; 7 mmol)
Number of subjects: 70
Study 26121539 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Distal Pancreatectomy (LDP)
Number of subjects: 112
Study 26121539 — intervention group
Group type: COMPARATOR
Intervention: Open Distal Pancreatectomy (ODP)
Number of subjects: 112
Study 24127467 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 104
Study 24127467 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical care (IMC)
Number of subjects: 104
Study 20484610 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric-retentive extended-release formulation of gabapentin
Number of subjects: 0
Study 20484610 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric-retentive extended-release formulation of gabapentin with food
Number of subjects: 0
Study 20484610 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release formulation of gabapentin
Number of subjects: 0
Study 18503113 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization surgery
Number of subjects: 10
Study 17003433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocular Response Analyzer (ORA)
Number of subjects: 48
Study 17003433 — intervention group
Group type: COMPARATOR
Intervention: Goldmann Applanation Tonometry (GAT)
Number of subjects: 48
Study 17003433 — intervention group
Group type: EXPERIMENTAL
Intervention: Central Corneal Thickness (CCT)
Number of subjects: 48
Study 12927650 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentives
Number of subjects: 96
Study 12927650 — intervention group
Group type: COMPARATOR
Intervention: Outreach
Number of subjects: 96
Study 11012558 — intervention group
Group type: COMPARATOR
Intervention: S 17092 100 mg
Number of subjects: 36
Study 11012558 — intervention group
Group type: COMPARATOR
Intervention: S 17092 800 mg
Number of subjects: 36
Study 11012558 — intervention group
Group type: COMPARATOR
Intervention: S 17092 1200 mg
Number of subjects: 36
Study 11012558 — intervention group
Group type: COMPARATOR
Intervention: S 17092 (all doses)
Number of subjects: 36
Study 8881815 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg budesonide
Number of subjects: 176
Study 8881815 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg budesonide
Number of subjects: 176
Study 8881815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 1384078 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. opiate by signalled self-injection
Number of subjects: 6
Study 1384078 — intervention group
Group type: COMPARATOR
Intervention: i.v. opiate by un-signalled infusion
Number of subjects: 6
Study 1384078 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 6
Study 4011463 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid restriction (8%-10% weight loss)
Number of subjects: 50
Study 4011463 — intervention group
Group type: COMPARATOR
Intervention: Fluid restriction (13%-15% weight loss)
Number of subjects: 50
Study 4011463 — intervention group
Group type: EXPERIMENTAL
Intervention: hsPDA presence
Number of subjects: 50
Study 4011463 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical ductal murmur
Number of subjects: 50
Study 31516731 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg + Lidocaine 2%
Number of subjects: 160
Study 31516731 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Lidocaine 2%
Number of subjects: 160
Study 31516731 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg + Placebo
Number of subjects: 160
Study 31516731 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Placebo
Number of subjects: 160
Study 30424793 — intervention group
Group type: EXPERIMENTAL
Intervention: High illuminance lighting (1500-2000 lx)
Number of subjects: 43
Study 30424793 — intervention group
Group type: COMPARATOR
Intervention: Standard ambient fluorescent lighting
Number of subjects: 43
Study 27940690 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal hypoglycemia
Number of subjects: 745
Study 27940690 — intervention group
Group type: COMPARATOR
Intervention: Normoglycemic controls
Number of subjects: 745
Study 24859962 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track surgery (FTS)
Number of subjects: 71
Study 24859962 — intervention group
Group type: COMPARATOR
Intervention: Routine management (Control)
Number of subjects: 71
Study 22313075 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilator hyperinflation
Number of subjects: 46
Study 22313075 — intervention group
Group type: COMPARATOR
Intervention: Manual hyperinflation
Number of subjects: 46
Study 21030718 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 94
Study 21030718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 18728597 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen matrix during hemicraniectomy
Number of subjects: 34
Study 18728597 — intervention group
Group type: COMPARATOR
Intervention: Conventional procedure (Control)
Number of subjects: 34
Study 15766617 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent Internet CME (mCME) intervention consisting of four case-based learning modules, tailored in real time, and included office-level feedback of chlamydia screening rates.
Number of subjects: 191
Study 15766617 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison offices) without the mCME intervention.
Number of subjects: 191
Study 12614927 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral movement/stimulation group (active neuromuscular stimulation: 5 s/trial, 90 trials/day, biphasic waveform for 4 days over 2 weeks)
Number of subjects: 20
Study 12614927 — intervention group
Group type: COMPARATOR
Intervention: Unilateral movement/stimulation group (active neuromuscular stimulation: 5 s/trial, 90 trials/day, biphasic waveform for 4 days over 2 weeks)
Number of subjects: 20
Study 12614927 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral movement/stimulation group
Number of subjects: 20
Study 10194427 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem cell factor (SCF) at 20 micrograms/kg/d plus Filgrastim at 10 micrograms/kg/d
Number of subjects: 203
Study 10194427 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim alone at 10 micrograms/kg/d
Number of subjects: 203
Study 8669327 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete hormone blockade (CHB)
Number of subjects: 102
Study 8669327 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (orchidectomy)
Number of subjects: 102
Study 2228327 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular atropine (0.02 mg/kg)
Number of subjects: 6
Study 481057 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalamonal
Number of subjects: 498
Study 481057 — intervention group
Group type: COMPARATOR
Intervention: Valium
Number of subjects: 498
Study 31584144 — intervention group
Group type: EXPERIMENTAL
Intervention: mMitra voice messages (intervention group)
Number of subjects: 2016
Study 29857497 — intervention group
Group type: EXPERIMENTAL
Intervention: HP diet with ≥4 weekly servings of lean beef (B)
Number of subjects: 120
Study 29857497 — intervention group
Group type: COMPARATOR
Intervention: HP diet restricted in all red meats (NB)
Number of subjects: 120
Study 29857497 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (B and NB)
Number of subjects: 120
Study 26417901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual liquid birch pollen preparation (SB) 3333 AUN/ml
Number of subjects: 269
Study 26417901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual liquid birch pollen preparation (SB) 10,000 AUN/ml
Number of subjects: 269
Study 26417901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual liquid birch pollen preparation (SB) 20,000 AUN/ml
Number of subjects: 269
Study 26417901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual liquid birch pollen preparation (SB) 40,000 AUN/ml
Number of subjects: 269
Study 26417901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 24271139 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative sRAGE levels
Number of subjects: 90
Study 24271139 — intervention group
Group type: EXPERIMENTAL
Intervention: sRAGE kinetics
Number of subjects: 90
Study 24271139 — intervention group
Group type: COMPARATOR
Intervention: Age and euroSCORE
Number of subjects: 90
Study 24271139 — intervention group
Group type: COMPARATOR
Intervention: Preoperative sRAGE values
Number of subjects: 90
Study 24271139 — intervention group
Group type: COMPARATOR
Intervention: 30-day mortality
Number of subjects: 90
Study 22337315 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory exercise with elastic chest band (EG)
Number of subjects: 16
Study 22337315 — intervention group
Group type: COMPARATOR
Intervention: Inspiratory exercise without elastic chest band (CG)
Number of subjects: 16
Study 19189065 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI-Schnider
Number of subjects: 90
Study 19189065 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI-Marsh
Number of subjects: 90
Study 19189065 — intervention group
Group type: COMPARATOR
Intervention: MCI
Number of subjects: 90
Study 17495826 — intervention group
Group type: EXPERIMENTAL
Intervention: Median mini-laparotomy
Number of subjects: 40
Study 17495826 — intervention group
Group type: COMPARATOR
Intervention: Complete median laparotomy
Number of subjects: 40
Study 15356671 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% of energy from white wine
Number of subjects: 40